Prats, William H. Hyde, k : ; 1 Ham~tin, .Lazette Jackson, A r n m . Rudolph. Baylor Co ege o edi-effer--is Hospital, Department o f Pediatrics, Houston, Texas. P o t e n t i a l l y excessive C02 accumulation i n i n f a n t incubators has been reported by Gale, e t a1 (Pediatrics 60:453, 1977) . Because o f the p o t e n t i a l significance o f t h i s finding, we measured C02 concentrations ( % V/v) w i t h a Beckman LB2 i n f r a r e d analyzer i n Air-Shield model C-86 (AS) and Vickers model 79 (V) i n f a n t incubators. Measurements were made over 90 minute periods with a l l portholes closed. Samples were obtained near the i n f a n t ' s forehead, away from the stream o f exhaled gas. Each i n f a n t served as h i s own control i n the two incubators. 15 i n f a n t s weighing <3000 gms (1964 gms f 1 3 4~) and 15 i n f a n t s weighing >3000 gms (2957 gms f 153) were studied a t 30, 60 and 90 minutes. CC021 was elevated above the nursery environmental level (0.03%) f o r a l l i n f a n t s studied. Our findinas are (mean + P o t e n t i a l l y -s i g n i f i c a n t c?l2 l e v e l s may accumulaie when l a r g e r i n f a n t s are placed i n incubators. C02 l e v e l s were higher i n the V incubator compared to the AS i n both groups. Corticosteroids (CS) have been anecdotally report62 t o improve chronic lung disease (CLD) i n premature infants. Concern over equivocal r e s u l t s and long-term CNS e f f e c t s prompted us t o review our c l i n i c a l experience. Between 01/78 and 11/80 we cared f o r 16 premature i n f a n t s w i t h c l i n i c a l and X-ray diagnosis o f CLD, 02 requirement >30 days and AaD02 >I00 who received CS f o r >48 hrs (mean dose 4.04 + 1.66 mglkglday prednisone equivalent). A posit i v e response t o CS was defined as a >30% drop i n AaD02 by days 4-6 post introduction o f CS which was sustained f o r >7 days. Eight p o s i t i v e responses i n 8 i n f a n t s and 10 f a i l u r e s t o respond i n another 8 i n f a n t s were found. Responders had lower b i r t hweights (p <0.01), gestational ages (p <0.05) and gained more weight/day p r i o r t o CS (p (0.01) as compared t o nonresponders and decreased PC02 (p (0.05) pre-and post CS. There was no d i f f e rence between the two groups i n mean AaD02, weight a t time o f treatment, o r the dose given, X-ray appearance, postnatal age, m o r t a l i t y and duration o f 02 therapy. Nine i n f a n t s w i t h CLD who d i d not receive CS were selected as a control group. Only one had a dramatic but transient decrease i n 02 requirement s i m i l a r t o the defined p o s i t i v e response. I n conclusion, 50% o f i n f a n t s receiving.CS had a dramatic improvement i n t h e i r lung function. However, i t i s unclear whether t h i s treatment a l t e r e d t h e i r longterm outcome. CS responsiveness may be a function o f some unrecognized e t i 6 l o g i c difference o r complication o f CLD. Serial platelet counts, bleeding times, in vitro platelet aggregations, prothrombin times (PT), partial thromboplastin times (PTT), fibrinogens, and fibrin degradation products (FDP) were performed in 58 prematures (1500 grams to show the relationship of platelet and clotting disorders to IVH. IVH was detected by CT scan, real-time ultrasonography and/or autopsy. 17 had no intracranial hemorrhage (ICH), 11 had subarachnoid hemorrhage (SAH) only, and 30 had intraventricular hemorrhage (IVH). 12 died (2 SAH and 10 IVH). Mean Day 1 platelet counts were normal in all 3 groups. Initial platelet counts were ~150,000/mm3 in 26 of 30 infants who developed IVH, but by day 7 thrombocytopenia occurred in 14 (47%). Platelet dysfunction, however, was evident on day 1 in the group with IVH. Day 1 bleeding times were significantly longer (p<.02) in infants who developed IVH (6 mins.6; x + SEMI than in those without ICH (3.7+0.9). Maximum platelet aggregations to adenosine diphosphate (ADP) were significantly lower (p<.025) on day 1 in IVH infants (41.5%+4) than in those without ICH (55.4%54). By day 3, bleeding times-deteriorated (p<.05) in IVH infants while aggregations were similar to day 1. Initial PT's and/or PTT's were abnormal in 16/30 infants with IVH in contrast to 2/28 infants with SAH or no ICH (p<.05). Normal fibrinogens and negative FDP's ruled out DIC in all but 3 cases of IVH. These data suggest that platelet dysfunction as well as coagulation defects may predispose the premature infant to IVH. The e f f e c t o f f l u i d administration upon pharmacological closure o f the DA by intravenous I, was evaluated i n a prospective randomized study o f 23 preterm infants, less than age 7 days, whose b i r t h weight varied between 600 and 1800 grams (average = 1255). A l l i n f a n t s required assisted v e n t i l a t i o n and had signs of s i g n i f i c a n t l e f t t o r i g h t DA shunting w i t h cardiomegaly, precordial hyperactivity, bounding peripheral pulses, and increased echo LA/Ao r a t i o . Total f l u i d administration t o 14 i n f a n t s i n Group 1 was < 90 ml/kg during the 24 hours p r i o r t o administrat i o n o f I. Group 2 consisted o f 9 i n f a n t s receiving > 90 ml/kg i n t h i s time period. One i n f a n t i n each group required surgical l i g a t i o n o f the DA a f t e r two I doses (0.2 mg/kg/dose) f a i l e d . Twenty-one i n f a n t s (91.3%) closed t h e i r DA w i t h I. The number o f doses o f I required was r e l a t e d The mortality for newborns with early onset group B beta hemolytic streptococcal sepsis (GBSS) remains high (50-80%) despite specific antibiotic and pressor therapy. The four-to-five day old newborn rat model was used to evaluate two nonsteroidal antiinflammatory drugs in the therapy of GBSS. We compared intraperitoneal (IP) indomethacin 3 mg/kg (INDO) and ibuprofen 4 mg/kg (IBUP) to sterile water controls in rats that had been injected subcutaneously (SQ) with two strains (GBS 1,GBS 2) of Type 111 group B strep grown to log-phase in Todd-Hewitt broth. The therapies ( 0 . 0 5~~ IP) and micro-organisms ( 0 . 0 5~~ SQ) were injected simultaneouslv. Per cent survival (% S) at 24 hours was recorded and lethal doses (LD) for controls were.calculated:
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EVALUATION OF THE
In the neonatal rat model, INDO significantly improved 24 hour survival in both the LD and LD groups. At an LD , INDO failed to improve surviaal while8?13LJp did. This dat20suggesta that after further studies INDO and IBUP--both prostaglandin inhibitors and anti-inflammatory agents--may become useful adjuvants to present treatment of early onset GBSS.
